Trademarkia Logo

Canada

C$
KEPTEMRY
REGISTERED

on 9 Dec 2022

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1941839 filed on 21st Jan 2019

Registration Number

TMA1155725 registered on 9th Dec 2022

Registration expiry Date

9th Dec 2032

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

KEPTEMRY

Trademark usage description

pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune dise Read More

Classification Information


Class [005]
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain


Classification kind code

11

Mark Details


Serial Number

1941839

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 24th Aug 2022
Registration Pending
Submitted for opposition 191
on 24th Aug 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 1st Jun 2022
Advertised
Submitted for opposition 26
on 28th Mar 2022
Approved
Submitted for opposition 27
on 28th Mar 2022
Approval Notice Sent
Submitted for opposition 22
on 22nd Mar 2022
Search Recorded
Submitted for opposition 48
on 1st Feb 2022
Agent Changed
Submitted for opposition 31
on 24th Jan 2019
Formalized
Submitted for opposition 1
on 22nd Jan 2019
Created
Submitted for opposition 30
on 21st Jan 2019
Filed